BALDUINI, WALTER
 Distribuzione geografica
Continente #
NA - Nord America 9.153
EU - Europa 6.416
AS - Asia 2.299
OC - Oceania 35
SA - Sud America 20
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 12
Totale 17.951
Nazione #
US - Stati Uniti d'America 9.106
GB - Regno Unito 2.350
CN - Cina 1.649
UA - Ucraina 1.082
IT - Italia 944
SE - Svezia 632
TR - Turchia 462
FI - Finlandia 415
DE - Germania 348
IE - Irlanda 197
FR - Francia 94
RU - Federazione Russa 93
BE - Belgio 57
PL - Polonia 51
CA - Canada 44
SG - Singapore 33
AU - Australia 32
JP - Giappone 31
IN - India 30
AT - Austria 29
NL - Olanda 24
KR - Corea 23
ES - Italia 20
RO - Romania 19
IR - Iran 13
EU - Europa 12
CH - Svizzera 10
SI - Slovenia 10
BR - Brasile 9
HK - Hong Kong 9
HR - Croazia 8
VN - Vietnam 8
KE - Kenya 7
PK - Pakistan 7
AL - Albania 5
KZ - Kazakistan 5
SM - San Marino 5
BY - Bielorussia 4
HU - Ungheria 4
SA - Arabia Saudita 4
TG - Togo 4
AR - Argentina 3
ID - Indonesia 3
IL - Israele 3
LB - Libano 3
NZ - Nuova Zelanda 3
TW - Taiwan 3
AM - Armenia 2
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
CO - Colombia 2
EG - Egitto 2
IM - Isola di Man 2
JM - Giamaica 2
LU - Lussemburgo 2
PH - Filippine 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BD - Bangladesh 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
GR - Grecia 1
IS - Islanda 1
JO - Giordania 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MX - Messico 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 17.951
Città #
Southend 2.106
Woodbridge 1.393
Fairfield 1.153
Houston 934
Jacksonville 870
Ann Arbor 666
Chandler 578
Ashburn 532
Cambridge 497
Seattle 484
Nanjing 466
Wilmington 433
Izmir 331
Urbino 201
Dublin 190
Nanchang 190
Helsinki 180
Beijing 151
Princeton 131
New York 116
San Mateo 114
Hangzhou 97
Tianjin 92
Shenyang 90
Changsha 87
Hebei 74
Bremen 71
Boardman 64
Jiaxing 64
Kunming 62
Velikiy Novgorod 61
Brussels 57
San Diego 55
Dearborn 54
Istanbul 53
Jinan 49
Mülheim 48
Kraków 39
London 38
Düsseldorf 31
Toronto 31
San Francisco 30
Munich 28
Taizhou 28
Rome 26
Vienna 26
Kocaeli 24
Lanzhou 24
Ningbo 21
Zhengzhou 20
Milan 18
Venice 18
Guangzhou 17
Seongnam 17
Singapore 17
Wuppertal 17
Bologna 16
Changchun 16
Haikou 16
West Jordan 16
Auburn Hills 14
Des Moines 14
Leawood 14
Redwood City 13
Shanghai 13
Amsterdam 12
Melbourne 11
Mcallen 10
Canberra 9
Norwalk 9
Pomezia 9
Acton 8
Ancona 8
Ardabil 8
Cagliari 8
Fuzhou 8
Jesi 8
Macerata 8
Orange 8
Scottsdale 8
Colli Del Tronto 7
Hounslow 7
Kilburn 7
Phoenix 7
Washington 7
Focsani 6
Grafing 6
Lappeenranta 6
Mountain View 6
Mumbai 6
Pesaro 6
Portland 6
Timisoara 6
Tokyo 6
Trieste 6
Aktobe 5
Bari 5
Catania 5
Chiswick 5
Fano 5
Totale 13.648
Nome #
1,3 dideazaadenosine is a mitogen for cultured mammalian cells. 367
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 319
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DERIVATIVES AS LIGANDS AT THE GLYCINE-BINDING SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR 313
1-Aminocyclopropane-1-carboxylic acid derivatives as ligands at the glicine-site of the NMDA receptor. 295
Rapid modulation of the silent information regulator 1 by melatonin after hypoxia-ischemia in the neonatal rat brain 288
Extended role of necrotic cell death after hypoxia-ischemia-induced neurodegeneration in the neonatal rat 248
Microencephalic rats as a model for cognitive disorders. 225
New therapeutic strategies in perinatal stroke 223
Melatonin reduces endoplasmic reticulum stress and preserves sirtuin 1 expression in neuronal cells of newborn rats after hypoxia-ischemia 216
The study of the mechanism of arsenite toxicity in respiration-deficient cells reveals that NADPH oxidase-derived superoxide promotes the same downstream events mediated by mitochondrial superoxide in respiration-proficient cells 214
Experimental models of hypoxic-ischemic encephalopathy: hypoxia-ischemia in the immature rat 207
Mitochondrial ascorbic acid prevents mitochondrial O2.- formation, an event critical for U937 cell apoptosis induced by arsenite through both autophagic-dependent and independent mechanisms 207
Caspase-3 and calpain activities after acute and repeated ethanol administration during the rat brain growth spurt 203
Autophagy in hypoxia-ischemia induced brain injury 199
NOCTURNAL HYPERACTIVITY INDUCED BY PRENATAL METHYLAZOXYMETHANOL ADMINISTRATION AS MEASURED IN A COMPUTERIZED RESIDENTIAL MAZE 196
LONG-LASTING TOLERANCE TO STIMULATORY EFFECTS BY PERINATAL CAFFEINE TREATMENT 195
Simvastatin reduces caspase-3 activation and inflammatory markers induced by hypoxia-ischemia in the newborn rat 190
Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic-ischemic brain injury in rats 188
CHRONIC CAFFEINE TREATMENT AND ADENOSINE RECEPTORS 188
Increased autophagy reduces endoplasmic reticulum stress after neonatal hypoxia–ischemia: Role of protein synthesis and autophagic pathways 186
MICROENCEPHALIC RATS AS A MODEL FOR COGNITIVE DISORDERS 186
Autophagy researchers 185
Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia 180
The use of melatonin in hypoxic-ischemic brain damage: an experimental study 179
The Synthetic Cannabinoid URB447 Reduces Brain Injury and the Associated White Matter Demyelination After Hypoxia-Ischemia in Neonatal Rats 179
Triflusal reduces cerebral ischemia induced inflammation in a combined mouse model of Alzheimer's disease and stroke 175
Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage 174
AUTORADIOGRAPHIC LOCALIZATION OF [3H]THIOCOLCHICOSIDE BINDING SITES IN THE RAT BRAIN AND SPINAL CORD 171
Modulation of muscarinic receptor-stimulated phosphoinositide breakdown by sulfhydryl group modification is a general response in different rat brain regions and depends on the stage of brain development. 169
Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats 167
Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4 166
Protective role of autophagy in neonatal hypoxia-ischemia induced brain injury 166
REGIONAL DEVELOPMENT OF CARBACHOL-, GLUTAMATE-, NOREPINEPHRINE-, AND SEROTONIN-STIMULATED PHOSPHOINOSITIDE METABOLISM IN RAT BRAIN 164
Melatonin modulates neonatal brain inflammation through endoplasmic reticulum stress, autophagy, and miR-34a/silent information regulator 1 pathway 163
SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF 2-(4-CHLORO-3-HYDROXYPHENYL)ETHYLAMINE AND N,N-DIALKYL DERIVATIVES AS DOPAMINE RECEPTOR LIGANDS 160
EFFECT OF PRENATAL TREATMENT WITH METHYLAZOXYMETHANOL ON CARBACHOL-, NOREPINEPHRINE- AND GLUTAMATE-STIMULATED PHOSPHOINOSITIDE METABOLISM IN THE NEONATAL, YOUNG AND ADULT OFFSPRING 160
Inhibition of nucleic acids and protein synthesis by deazaadenosine derivatives: a study on structure-activity relationships 158
Free iron, total F(2)-isoprostanes and total F(4)-neuroprostanes in a model of neonatal hypoxic-ischemic encephalopathy: neuroprotective effect of melatonin 158
Inhibition of rapamycin-induced autophagy causes necrotic cell death associated with Bax/Bad mitochondrial translocation 156
Melatonin pharmacokinetics and dose extrapolation after enteral infusion in neonates subjected to hypothermia 156
TREATMENT WITH METHYLAZOXYMETHANOL AT DIFFERENT GESTATIONAL DAYS: PHYSICAL, REFLEX DEVELOPMENT AND SPONTANEOUS ACTIVITY IN THE OFFSPRING 155
BEHAVIORAL AND BIOCHEMICAL EFFECTS OF EARLY POSTNATAL PARATHION EXPOSURE IN THE RAT 153
Preclinical randomized controlled multicenter trials (pRCT) in stroke research: a new and valid approach to improve translation? 153
Involvement of miRNAs in Placental Alterations Mediated by Oxidative Stress 152
ADENOSINE AND 2-CHLOROADENOSINE DEAZA-ANALOGUES AS ADENOSINE RECEPTOR AGONISTS 151
Simvastatin acutely reduces ischemic brain damage in the immature rat via Akt and CREB activation 150
BEHAVIORAL AND BIOCHEMICAL EFFECTS OF POSTNATAL PARATHION EXPOSURE IN THE RAT 146
SELECTIVE ALTERATION IN B-50 (GAP-43) PHOSPHORYLATION IN BRAIN AREAS OF ANIMALS CHARACTERIZED BY COGNITIVE IMPAIRMENT 145
Application of a non-electrophysiological method to study binding affinity and efficacy of glicine analogs to the glicine site of the NMDA receptor-ion channel complex. 143
DEVELOPMENTAL NEUROTOXICITY OF ETHANOL: IN VITRO INHIBITION OF MUSCARINIC RECEPTOR-STIMULATED PHOSPHOINOSITIDE METABOLISM IN BRAIN FROM NEONATAL BUT NOT ADULT RATS 141
CHRONIC CHLORDIAZEPOXIDE TREATMENT ON ADULT AND NEWBORN RATS: EFFECTS ON GABA-BENZODIAZEPINE SYSTEM 141
SIMVASTATIN PROTECTS AGAINST THE LONG-LASTING BEHAVIORAL AND MORPHOLOGICAL CONSEQUENCES OF A NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURY 140
Expression of hexokinase mRNA in human hippocampus 138
Chronic caffeine treatment: its relevance for studying the functional role of adenosine receptors 138
Neuroprotective Effect of Simvastatin in Stroke: A Comparison Between Adult and Neonatal Rat Models of Cerebral Ischemia 137
Pharmaceutical composition for the parenteral administration of melatonin, and a process for its preparation 137
POTASSIUM IONS POTENTIATE THE MUSCARINIC RECEPTOR-STIMULATED PHOSPHOINOSITIDE METABOLISM IN CEREBRAL CORTEX SLICES: A COMPARISON OF NEONATAL AND ADULT RATS 136
Tossicologia generale e applicata ai farmaci 135
Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates 133
2-(SUBSTITUTED)AMINO-2,8-DIAZASPIRO[4,5]DECAN-1,3-DIONES AS POTENTIAL MUSCARINIC AGONISTS: SYNTHESIS, MODELING AND BINDING STUDIES 132
SYNTHESIS AND DOPAMINE RECEPTOR AFFINITIES OF 2-(4-FLUORO-3 HYDROXYPHENYL) ETHYLAMINE AND N-SUBSTITUTED DERIVATIVES 132
DEVELOPMENTAL NEUROTOXICITY OF ETHANOL: FURTHER EVIDENCE FOR AN INVOLVEMENT OF MUSCARINIC RECEPTOR-STIMULATED PHOSPHOINOSITIDE HYDROLYSIS 131
INTERACTION OF ETHANOL AND ANOXIA WITH MUSCARINIC RECEPTOR-STIMULATED PHOSPHOINOSITIDE METABOLISM DURING BRAIN DEVELOPMENT 130
The CB1 Antagonist/CB2 Agonist URB447 Confers Neuroprotection after Neonatal Hypoxia-ischemia 130
Autophagy in hypoxia-ischemia induced brain injury: Evidence and speculations 128
Sex differences in the acute ethanol induced hypertriglyceridimia in fasted rats and humans 128
“Experimental Models of Hypoxic-Ischemic Encephalopathy: Hypoxia-Ischemia in the Immature Rat” 128
Tossicologia cardiaca e polmonare 128
CHOLINERGIC HYPERINNERVATION IN THE CEREBRAL CORTEX OF MICOENCEPHALIC RATS DOES NOT RESULT IN MUSCARINIC RECEPTOR DOWN-REGULATION OR IN ALTERATION OF RECEPTOR-STIMULATED PHOSPHOINOSITIDE METABOLISM 128
New pharmacological approaches in infants with hypoxic-ischemic encephalopathy 127
Long-lasting behavioral alterations following an hypoxic/ischemic brain injury in neonatal rats 127
The muscarinic receptor-stimulated phosphoinositide metabolism as a potential target for the neurotoxicity of ethanol during brain development 126
Tossicocinetica e tossicogenetica 124
DISPLACEMENT OF |3H|-N6-CYCLOEXYLADENOSINE BINDING TO RAT CORTICAL MEMBRANES BY AN HYDROALCOHOLIC EXTRACT OF VALERIANA OFFICINALIS 123
INTERACTION OF SOME 2-HYDROXYBENZYLPIPERIDINES WITH DOPAMINE RECEPTORS 122
Nurturing a young field 121
TREATMENT WITH METHYLAZOXYMETHANOL AT DIFFERENT GESTATIONAL DAYS: TWO-WAY SHUTTLE BOX AVOIDANCE AND RESIDENTIAL MAZE ACTIVITY IN RAT OFFSPRING 120
Novel 3-O-glycosyl-3-demethylthiocolchicines as ligands for glycine and gamma-aminobutyric acid receptors. 117
EARLY POSTNATAL CHLORDIAZEPOXIDE ADMINISTRATION: PERMANENT BEHAVIORAL EFFECTS IN THE MATURE RAT AND POSSIBLE INVOLVEMENT OF THE GABA-BENZODIAZEPINE RECEPTOR SYSTEM 115
Moderate ethanol consumption and cigarette smoking habit fail to affect acutely ethanol induced hypertrigliceridimia in humans 114
Simultaneous determination of new-generation antidepressant in plasma by gas chromatography-mass spectrometry 113
URB602, a Monoacylglycerol Lipase Inhibitor, Protects from the Long-term Consequences of a Neonatal Hypoxic-ischemic Brain Injury in Rats 112
SYNTHESIS AND DOPAMINE RECEPTORS BINDING AFFINITY OF 2-(3-FLUORO-4-HYDROXYPHENYL)ETHYLAMINE AND ITS N-ALKYL DERIVATIVES 111
Prophylactic but not delayed administration of simvastatin protects against long-lasting cognitive and morphological consequences of neonatal hypoxic-ischemic brain injury, reduces interleukin-1beta and tumor necrosis factor-alpha mRNA induction, and does not affect endothelial nitric oxide synthase expression 109
Effetti tossici su sistema endocrino, immunitario e cute 109
3-Demetoxy-3-glycosylaminothiocolchicines: synthesis of a new class of putative muscle relaxant compounds. 109
INHIBITION OF NUCLEIC ACIDS AND PROTEIN SYNTESIS BY DEAZAADENOSINE DERIVATIVES: A STUDY ON STRUCTURE-ACTIVITY RELATIONSHIPS 107
DEVELOPMENTAL CHANGES IN MUSCARINIC RECEPTOR-STIMULATED PHOSPHOINOSITIDE METABOLISM IN RAT BRAIN 107
Simvastatin preconditioning confers neuroprotection against hypoxia-ischemia induced brain damage in neonatal rats via autophagy and silent information regulator 1 (SIRT1) activation 103
ADMINISTRATION OF ETHANOL DURING THE RAT'S BRAIN GROWTH SPURT CAUSES DOSE - DEPENDENT MICROENCEPHALY AND INHIBITION OF MUSCARINIC RECEPTOR - STIMULATED PHOSPHOINOSITIDE METABOLISM 101
Melatonin acts in synergy with hypothermia to reduce oxygen-glucose deprivation (OGD)-induced cell death in rat hippocampus organotypic slice cultures 101
TOSSICOLOGIA: I fondamenti dell'azione delle sostanze tossiche - V Edizione 100
Farmacovigilanza e fitovigilanza 99
CHARACTERIZATION OF CHOLINERGIC MUSCARINIC RECEPTORS-STIMULATED PHOSPHOINOSITIDE METABOLISM IN BRAIN FROM IMMATURE RATS 98
Characterization of [3H]thiocolchicoside binding sites in rat spinal cord and cerebral cortex 98
Perinatal Brain Injury: Mechanisms and Potential Pharmacological Therapies: The role of SIRT1 in the neuroprotective effect of melatonin and of endothelin-1 in oligodendrocyte progenitor cell development 98
ADENOSINE MODULATION OF HISTAMINE-STIMULATED PHOSPHOINOSITIDE METABOLISM IN RAT CORTICAL SLICES 97
MODERATE ETHANOL CONSUMPTION AND CIGARETTE SMOKING HABIT TO FAIL TO AFFECT ACUTELY ETHANOL INDUCED HYPERTRIGLYCERIDIMIA IN HUMANS 96
Guidelines for the use and interpretation of assays for monitoring autophagy (review) 96
PHARMACOLOGICAL CHARACTERIZATION OF CHIRAL MUSCARINIC ANTAGONISTS CIS-2-PHENYL-2-CYCLOHEXYL-R-[(DIMETHYLAMINO)-METHYL]-1,3-OXATHIOLANE 3-OXIDE METHIODIDES 95
Totale 15.453
Categoria #
all - tutte 58.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.972 777 143 228 852 143 345 371 336 216 276 119 166
2020/20212.442 91 218 141 278 190 202 177 158 297 256 316 118
2021/20221.612 158 175 175 230 22 20 67 110 108 85 39 423
2022/20232.106 265 132 61 211 184 443 23 155 317 83 136 96
2023/2024677 70 54 49 71 45 146 49 45 10 61 27 50
2024/2025127 127 0 0 0 0 0 0 0 0 0 0 0
Totale 18.200